FLUOROURACIL AS AN ADJUVANT TO COLORECTAL CANCER SURGERY

被引：2
|
作者：
LI, MC
机构：
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1976年 / 236卷 / 21期
关键词：
D O I：
10.1001/jama.1976.03270220014010
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2392 / 2392
页数：1
相关论文
共 50 条
  • [41] ADJUVANT CHEMOTHERAPY WITH 5-FLUOROURACIL, VINCRISTINE AND CCNU FOR PATIENTS WITH DUKES C COLORECTAL-CANCER
    HAFSTROM, L
    DOMELLOF, L
    RUDENSTAM, CM
    NORRYD, C
    BERGMAN, L
    NILSSON, T
    HANSSON, K
    WAHLBY, L
    ASKLOF, G
    KUGELBERG, C
    BRITISH JOURNAL OF SURGERY, 1990, 77 (12) : 1345 - 1348
  • [42] Potent effects of adjuvant chemotherapy using 5-fluorouracil + leucovorin on DNA aneuploid colorectal cancer
    Yamamoto T.
    Matsumoto K.
    Iriyama K.
    International Journal of Clinical Oncology, 1998, 3 (3) : 165 - 170
  • [43] Noncoding miRNAs as novel prognostic factor for 5-fluorouracil adjuvant therapy in colorectal cancer.
    Xi, Y.
    Formentini, A.
    Kornmann, M.
    Ju, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 173S - 173S
  • [44] Pharmacokinetic and demographic markers of 5-fluorouracil toxicity in 181 patients on adjuvant therapy for colorectal cancer
    Gusella, M.
    Crepaldi, G.
    Barile, C.
    Bononi, A.
    Menon, D.
    Toso, S.
    Scapoli, D.
    Stievano, L.
    Ferrazzi, E.
    Grigoletto, F.
    Ferrari, M.
    Padrini, R.
    ANNALS OF ONCOLOGY, 2006, 17 (11) : 1656 - 1660
  • [45] Adjuvant therapy with raltitrexed in patients with colorectal cancer intolerant of 5-fluorouracil: British Columbia cancer agency experience
    Wilson, Kenneth S.
    Fitzgerald, Catherine A.
    Barnett, Jeff B.
    Gill, Sharlene
    Khoo, Kong E.
    CANCER INVESTIGATION, 2007, 25 (08) : 711 - 714
  • [46] Chemoradiotherapy with 5-fluorouracil/leucovorin, surgery and adjuvant chemotherapy for locally advanced rectal cancer
    Baur, M.
    Horvath, M.
    Stattner, S.
    Schratter-Sehn, A.
    Horvath, B.
    Sellner, F.
    Hudec, M.
    Klimpfinger, M.
    Dittrich, C.
    Karner, J.
    ONCOLOGY LETTERS, 2010, 1 (01) : 189 - 194
  • [47] Thymidylate Synthase Gene Polymorphism and Survival of Colorectal Cancer Patients Receiving Adjuvant 5-Fluorouracil
    Sulzyc-Bielicka, Violetta
    Bielicki, Dariusz
    Binczak-Kuleta, Agnieszka
    Kaczmarczyk, Mariusz
    Pioch, Wieslawa
    Machoy-Mokrzynska, Anna
    Ciechanowicz, Andrzej
    Golebiewska, Magdalena
    Drozdzik, Marek
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2013, 17 (11) : 799 - 806
  • [48] 5 YEAR RESULTS OF A RANDOMIZED TRIAL OF ADJUVANT 5-FLUOROURACIL AND LEVAMISOLE IN COLORECTAL-CANCER
    WINDLE, R
    BELL, PRF
    SHAW, D
    BRITISH JOURNAL OF SURGERY, 1987, 74 (07) : 569 - 572
  • [49] Consumption of Lactose, Other FODMAPs and Diarrhoea during Adjuvant 5-Fluorouracil Chemotherapy for Colorectal Cancer
    Holma, Reetta
    Laatikainen, Reijo
    Orell, Helena
    Joensuu, Heikki
    Peuhkuri, Katri
    Poussa, Tuija
    Korpela, Riitta
    Osterlund, Pia
    NUTRIENTS, 2020, 12 (02)
  • [50] Early hematological toxicity of adjuvant perioperative intraportal and intravenous chemotherapy with fluorouracil, mitomycin and heparin in colorectal cancer
    Weber, W
    Maibach, R
    Laffer, U
    Metzger, U
    Egeli, R
    Lorenz, M
    Aeberhard, P
    DupontLampert, V
    Nothiger, F
    Ruedi, T
    Castiglione, M
    ANTICANCER RESEARCH, 1995, 15 (5B) : 2197 - 2200
12345